| JEVIX | VEMRX | JEVIX / VEMRX | |
| Total Expense Ratio | 1.01 | 0.07 | 1,443% |
| Annual Report Gross Expense Ratio | 1.28 | 0.07 | 1,829% |
| Fund Existence | 15 years | 15 years | - |
| Gain YTD | 30.164 | 23.076 | 131% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250000 | 100000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 130M | 141B | 0% |
| Annual Yield % from dividends | 1.08 | 2.83 | 38% |
| Returns for 1 year | 2.34 | 20.88 | 11% |
| Returns for 3 years | 10.00 | 42.56 | 23% |
| Returns for 5 years | 0.13 | 22.51 | 1% |
| Returns for 10 years | 47.00 | 88.23 | 53% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| NBMIX | 55.04 | N/A | N/A |
| Neuberger Berman Small Cap Growth Inv | |||
| ATEYX | 166.58 | N/A | N/A |
| AB Sustainable Global Thematic Advisor | |||
| PHPSX | 27.74 | N/A | N/A |
| ProFunds Pharmaceuticals UltraSector Svc | |||
| JHDCX | 19.66 | N/A | N/A |
| JPMorgan Hedged Equity 2 C | |||
| HFSFX | 17.05 | N/A | N/A |
| Hartford Schroders Intl Cntrrn Val F | |||